Robert B. Ford is Abbott's Chairman of the Board and Chief Executive Officer. He assumed the role of Chairman in December 2021, having been appointed President and Chief Executive Officer in March ...
COVID-19 testing will remain an important tool as our global communities continue to experience seasonal waves of COVID-19. The BinaxNOW COVID-19 Self Test is identical to the professional-use test ...
Living with diabetes can often mean making choices between what you "should" do and what you "want" to do. FreeStyle Libre 2 helps you do both at the same time. Along with its excellent accuracy, it's ...
At Abbott, operating sustainably and responsibly is the bedrock of our impact on society. We continually strive to be well-informed about the issues that are of material importance to Abbott, our ...
The AMPLATZER Piccolo™ Occluder is a percutaneous, transcatheter occlusion device intended for the nonsurgical closure of a patent ductus arteriosus (PDA). Pregnancy — Minimize radiation exposure to ...
"This product(s) and/or its manufacture and/or its use either alone or in combination with other product(s) are protected by one or more of the following patents: US7 ...
When people think about health and human dignity, the focus is often on aging or severe illness. To us, it's bigger. It's the freedom to live life liberated from the worry and weight of sickness, to ...
Below is the Abbott Laboratories Code of Business Conduct (the “Code”), effective January 1, 2015. The Code now makes better use of technology to communicate with Abbott employees and other ...
Lisa Earnhardt is Abbott’s Executive Vice President and Group President, Medical Devices. She was appointed to this role in December 2023. Previously, Lisa served as Abbott’s Executive Vice President, ...